Advancement in predictive biomarkers for gestational diabetes mellitus diagnosis and related outcomes: a scoping review
Objective Gestational diabetes mellitus (GDM) is a metabolic disorder associated with adverse maternal and neonatal outcomes. While GDM is diagnosed by oral glucose tolerance testing between 24–28 weeks, earlier prediction of risk of developing GDM via circulating biomarkers has the potential to ris...
Saved in:
| Main Authors: | Fabricio Da Silva Costa, Hasini Rathnayake, Luhao Han, Cristiane Paganoti, Brett Dyer, Avinash Kundur, Indu Singh, Olivia J Holland |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2024-12-01
|
| Series: | BMJ Open |
| Online Access: | https://bmjopen.bmj.com/content/14/12/e089937.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Glycosylated fibronectin as a biomarker to predict gestational diabetes mellitus in the first trimester of pregnancy
by: Indu Lata, et al.
Published: (2025-06-01) -
Molecular signatures of preeclampsia subtypes determined through integrated weighted gene co-expression network analysis and differential gene expression analysis of placental transcriptomics
by: Luhao Han, et al.
Published: (2025-07-01) -
The Role of IL-6 and TNF-α as Early Biomarkers in the Prediction and Diagnosis of Gestational Diabetes Mellitus
by: Antonia Varthaliti, et al.
Published: (2025-07-01) -
RISK FACTORS AND DIAGNOSIS OF GESTATIONAL DIABETES MELLITUS
by: OKSANA N. Novikova, et al.
Published: (2017-09-01) -
Advancing Early Prediction of Gestational Diabetes Mellitus with Circular RNA Biomarkers
by: Joon Ho Moon, et al.
Published: (2025-05-01)